✦ LIBER ✦

Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients

✍ Scribed by I. FERNANDEZ-CADENAS; J. ALVAREZ-SABIN; M. RIBO; M. RUBIERA; M. MENDIOROZ; C. A. MOLINA; A. ROSELL; J. MONTANER

Book ID: 109152232
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 585 KB
Volume: 5
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2007.02665.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The long-term effects of metoprolol and

The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease

✍ R. A. Wright; A. M. Perrie; F. Stenhouse; K. G. M. M. Alberti; R. A. Riemersma; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 347 KB

Effects of baicalein isolated from roots

Effects of baicalein isolated from roots of Scutellaria baicalensis Georgi on interleukin 1β- and tumour necrosis factor α-induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 production in cultured human umbilical vein endothelial cells

✍ Yoshiyuki Kimura; Hiromichi Okuda; Kumi Yokoi (Hayashi); Nobutoshi Matsushita 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

The effects were examined of baicalein on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) production stimulated by interleukin-1␣ (IL-1␤) and tumour necrosis factor-␣ (TNF-␣) in cultured human vein umbilical endothelial cells (HUVECs). IL-1␤ and TNF-␣ increased

The 4G/5G polymorphism of the type 1 pla

The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome

✍ Dolors Tàssies; Gerard Espinosa; Francisco Jose Muñoz-Rodríguez; Carolina Freire 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Objective: To investigate the relationship between the 4g/5g polymorphism of the type 1 plasminogen activator inhibitor (pai-1) gene and thrombotic manifestations in patients with antiphospholipid syndrome (aps). ## Methods: We studied a total of 247 patients included in the following 4 groups